ASRT vs FFIV · rev $125.0M vs P/E 32, rev $3.09B
Assertio Therapeutics Inc (ASRT) versus F5 Networks Inc (FFIV) — a side-by-side from cached financials, not a winner call.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
F5 Networks Inc (FFIV) is a software - infrastructure company listed on NASDAQ.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
Latest reported FFIV revenue for 2025-09-30 was $3.09B. Net income was $692.4M. Revenue was up 9.7% from 2024-09-30 to 2025-09-30. FFIV currently screens at market cap $21.71B and trailing P/E 31.6.
ASRT currently screens at market cap $151.5M. FFIV currently screens at market cap $21.71B and trailing P/E 31.6.
Not investment advice. Open the ASRT and FFIV stock pages for the full models.
Not investment advice.